« Visit AACR Journals' Instructions for Authors |
The following types of articles will be considered for publication. Note that word counts are exclusive of references and Materials and Methods. Authors are advised that submissions not adhering to the guidelines provided below, including word counts, may be returned unreviewed. After completion of the review process, the Editors scientifically edit each article to improve their clarity, brevity, and quality.
Research Articles
Original studies offering broad impact across the entire discipline of cancer immunology including basic, pre-clinical, translational, and clinical investigations. The reports should be well-documented, novel, and significant to the field as a whole.
- 250-word abstract
- 5,000 words of text
- 7 tables and/or figures (Please keep the number of panels per figure to an absolute minimum)
- 50 references
Priority Briefs
Short, definitive reports of findings of high impact, significance, and timeliness. These reports receive an accelerated review. Papers submitted as Priority Briefs should include a section for Materials and Methods as well as Results and Discussion (Results and Discussion may be combined but Materials and Methods may not be combined with any other section).
- 200-word abstract
- 2,500 words of text
- 4 tables and/or figures (Please keep the number of panels per figure to an absolute minimum)
- 25 references
Cancer Immunology Miniatures
Miniatures are well-analyzed, provocative clinical cases or patient-based discovery that is immunologically insightful, yet not sufficiently developed for publication as a Research Article. These provide the basis for significant future research impacting clinical investigation and care.
- 200-word abstract
- 2,500 words of text
- 4 tables and/or figures (Please keep the number of panels per figure to an absolute minimum)
- 25 references
Review Articles (By Invitation Only)
Articles that review a timely subject important to those working in the field of cancer immunology. The length restrictions for this category of publication are provided below. Longer reviews will be considered at the discretion of the Editors.
- 200-word abstract
- 2,000 words of text
- 1 original figure with a maximum of 4 panels
- 30 references
Cancer Immunology at the Crossroads (By Invitation Only)
Perspectives that highlight the intersection of cancer immunology with other areas of cancer research and allied disciplines.
- 250-word abstract
- 2,500 words of text
- 1 original figure with a maximum of 4 panels (figure to be redrawn)
- 30 references
Masters of Immunology (By Invitation Only)
Primers on specific aspects of basic immunology that are of great relevance to cancer immunology. These short pieces by leading scientists are targeted to cancer researchers and physicians whose primary activities have not focused on immunology.
- 250-word abstract
- 2,500 words of text
- 1 original figure with a maximum of 4 panels (figure to be redrawn)
- 30 references
Letters to the Editor
Original correspondence comprised of scholarly commentary on subjects of importance and interest to the cancer immunology community, Letters to the Editor must relate to recently published Cancer Immunology Research articles. At the editors’ discretion, the Letter may be sent to various pertinent parties, including the author(s) of the cited article and other experts in the field, in order to grant them the opportunity to respond. Any such response would be vetted similarly and published in the same issue of the journal as the Letter.
- Letter title should read as "'Running title of the original article'Letter"
- 500 words of text
- 10 references. The first reference must cite the original article.
- 1 figure and/or table. Display items are permitted only if they show data that refute the conclusions of the originating article; figures or tables featuring unpublished data in support of the conclusions of the originating article will not be considered.
Cancer Immunology Research Editorial Office
American Association for Cancer Research | Publications Division
615 Chestnut Street | 17th Floor | Philadelphia, PA 19106-4404
Phone: (215) 440-9300 | Fax: (215) 446-7289 | E-mail: cancerimmunolres@aacr.org